Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 13 of 100
Health
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
By
Amanda Loudin
June 28, 2024
Tech
Meta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream
By
Sharon Goldman
June 25, 2024
Commentary
‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu outbreak
By
Carolyn Barber
June 24, 2024
Leadership
Forget expensive coaches, Paul Hudson, CEO of Sanofi turns to his three children for advice: ‘Through their eyes I get a glimpse into what the future looks like for the next generation’
By
Peter Vanham
June 20, 2024
Retail
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
By
Ryan Hogg
June 17, 2024
Health
Mold colonies and liquid-flooded air purifiers: CVS sourced medication from tainted factories—and it has twice the amount of recalls on store-brand drugs than competitors
By
Sasha Rogelberg
June 11, 2024
Politics
Biden’s plan to save money on Medicare drugs risks leaving shelves empty, pharmacists say
By
Susan Jaffe
and
KFF Health News
June 11, 2024
Health
Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers
By
Matthew Perrone
and
The Associated Press
June 11, 2024
Newsletters
Female CEOs used to run America’s top drugstores. But two powerful women were replaced this year as pharmacies face a national crisis
By
Maria Aspan
and
Joey Abrams
June 7, 2024
Health
‘You’re the smoking cessation counselor, you’re the suicide prevention counselor’—waves of pharmacy closures nationwide take a toll
By
The Associated Press
,
Tom Murphy
and
Kasturi Pananjady
June 3, 2024
Newsletters
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
By
Peter Vanham
and
Nicholas Gordon
May 29, 2024
Retail
Danish pharma giant Novo Nordisk’s office building is in danger of collapsing after a ‘massive fire’ broke out
By
Sanne Wass
,
Naomi Kresge
and
Bloomberg
May 23, 2024
Health
GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
By
Lindsey Leake
May 22, 2024
Health
How GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally
By
Ashleigh Furlong
,
Sabah Meddings
and
Bloomberg
May 21, 2024
Finance
Denmark’s economy shrinks 1.8% on reduced pharma production, showing extent of Novo Nordisk dependency
By
Sanne Wass
and
Bloomberg
May 21, 2024
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting...
By
Eva Roytburg
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House post
By
Eleanor Pringle